insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

DD · Dupont De Nemours, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · DD

1Y3Y5YMax
Sign in to download
AnnualQuarterly

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$6.85B$12.39B$12.07B$13.02B$14.34B$20.40B
Cost of Revenue$4.49B$7.88B$7.83B$8.40B$10.80B$13.52B
Gross Profit$2.36B$4.51B$4.23B$4.62B$3.54B$6.88B
R&D$193.00M$531.00M$508.00M$536.00M$618.00M$860.00M
SG&A$1.02B$1.55B$1.41B$1.47B$1.85B$2.23B
Total Operating Expenses------
D&A$647.00M$1.19B$1.15B$1.18B$1.46B$3.09B
Operating Income$200.00M$1.19B$504.00M$1.45B$2.20B($2.90B)
Interest Expense------
Income Tax$102.00M$414.00M($29.00M)$387.00M$392.00M($23.00M)
Net Income($779.00M)$703.00M$423.00M$5.87B$6.47B($2.95B)
EPS - Basic($1.87)$0.70$0.39$4.92$4.99($1.68)
EPS - Diluted($1.86)$0.70$0.39$4.92$4.97($1.68)

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$715.00M$1.85B$2.39B$3.66B$2.01B$2.54B
Accounts Receivable$910.00M$1.53B$1.51B$1.57B$2.06B$2.81B
Inventory$1.17B$2.13B$2.15B$2.33B$2.86B$3.73B
Accounts Payable$995.00M$1.72B$1.68B$2.10B$2.61B$2.96B
Current Assets$5.58B$6.36B$7.51B$11.27B$8.06B$10.88B
Total Assets$21.57B$36.64B$38.55B$41.35B$45.71B$70.90B
Current Liabilities$2.31B$4.80B$3.10B$3.73B$4.26B$4.70B
Long-term Debt--$7.86B$8.14B$10.63B($21.81B)
Total Liabilities$7.47B$12.84B$13.83B$14.34B$18.66B$31.83B
Stockholders' Equity$13.92B$23.35B$24.28B$26.57B$26.43B$38.50B
Retained Earnings($24.28B)($23.08B)($22.87B)($21.07B)($23.19B)($11.59B)

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$560.00M$2.32B$1.85B$588.00M$4.09B-
Investing Cash Flow($374.00M)($849.00M)$9.00B$8.92B($202.00M)-
Financing Cash Flow($1.75B)($1.85B)($7.59B)($7.67B)$3.24B-
CapEx$333.00M$579.00M$619.00M$743.00M$1.19B-
Free Cash Flow$227.00M$1.74B$1.23B($155.00M)$2.90B-

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin34.5%36.4%35.1%35.5%24.7%33.7%
Operating margin2.9%9.6%4.2%11.1%15.3%-14.2%
EBITDA margin12.4%19.3%13.7%20.2%25.5%1.0%
Net margin-11.4%5.7%3.5%45.1%45.1%-14.5%
Free cash flow margin3.3%14.1%10.2%-1.2%20.2%-
FCF / Net income-0.292.482.90-0.030.45-
R&D / Revenue2.8%4.3%4.2%4.1%4.3%4.2%
SG&A / Revenue14.9%12.5%11.7%11.3%12.9%11.0%
Effective tax rate-37.1%-7.4%6.2%5.7%-
Return on assets-3.6%1.9%1.1%14.2%14.1%-4.2%
Return on equity-5.6%3.0%1.7%22.1%24.5%-7.7%
Return on invested capital--1.6%3.9%5.6%-13.7%
Liquidity
Current ratio2.421.332.433.021.892.31
Quick ratio1.910.881.732.401.221.52
Cash ratio0.310.390.770.980.470.54
Leverage
Debt / Equity--0.320.310.40-0.57
Debt / Assets--0.200.200.23-0.31
Debt / EBITDA--4.763.102.91-110.72
Interest coverage------
Equity multiplier1.551.571.591.561.731.84
Liabilities / Assets0.350.350.360.350.410.45
Efficiency
Asset turnover0.320.340.310.310.310.29
Inventory turnover3.833.703.653.613.773.63
Days sales outstanding48d45d46d44d52d50d
Days inventory outstanding95d99d100d101d97d101d
Days payable outstanding81d80d78d91d88d80d
Cash conversion cycle63d64d68d54d61d71d
Valuation
P / E-45.7x81.8x5.8x6.8x-
P / B1.2x0.6x0.6x0.5x0.7x0.6x
P / S2.5x1.1x1.2x1.1x1.3x1.1x
EV / EBITDA19.1x4.8x12.1x7.2x7.4x-12.5x
Growth
Revenue growth (YoY)-44.7%2.6%-7.3%-9.2%-29.7%-5.2%
Revenue CAGR (3y)-19.3%-4.8%-16.0%-15.4%-33.2%-24.9%
Revenue CAGR (5y)-19.6%-10.5%-24.2%-23.0%--
Gross profit growth (YoY)-47.6%6.5%-8.3%30.6%-48.6%-7.8%
Operating income growth (YoY)-83.2%136.5%-65.2%-34.1%--511.2%
Net income growth (YoY)-66.2%-92.8%-9.3%--
EPS growth (YoY)-77.7%-92.0%-1.2%--
EPS CAGR (3y)--48.0%-94.3%44.5%-
EPS CAGR (5y)-0.8%-24.9%6.9%--
FCF growth (YoY)-87.0%42.0%----
FCF CAGR (5y)--6.5%---
Book value growth (YoY)-40.4%-3.8%-8.6%0.5%-31.3%-6.1%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$6.85B total
Diversified Industrials Segment$3.62B · 52.8%
Healthcare And Water Technologies Segment$3.23B · 47.2%

Product / service

$6.85B total
Industrial Technologies$2.00B · 29.2%
Healthcare Technologies$1.76B · 25.7%
Building Technologies$1.61B · 23.6%
Water Technologies$1.48B · 21.5%

Geographic

$7.56B total
US$3.19B · 42.2%
Asia Pacific$1.64B · 21.7%
EMEA$1.47B · 19.4%
CN$708.00M · 9.4%
Latin America$326.00M · 4.3%
CA$227.00M · 3.0%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

0.28
Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

4/9
Neutral
  • ✗Net income positive
  • ✓Operating cash flow positive
  • ✗ROA improved YoY
  • ✓Cash flow > net income
  • -Long-term debt decreased
  • ✓Current ratio improved
  • ✓No share dilution
  • ✗Gross margin improved
  • ✗Asset turnover improved

Peer comparison

Same SIC group: Plastic Materials, Synth Resins & Nonvulcan Elastomers

CompanyRevenue (last FY)Net marginROE
EMN$8.75B5.4%8.0%
AVNT$3.26B2.5%3.4%
TSE$2.97B-18.3%49.7%
DOW$39.97B-6.6%-16.4%
HXL$1.89B7.0%10.6%

Comparing DuPont de Nemours against the 5 most active filers in the same SIC group.

Dividends

$0.77/share trailing 12 months · +16.7% YoY

Ex-datePer share
May 15, 2026$0.2000
Mar 2, 2026$0.2000
Nov 28, 2025$0.2000
Aug 29, 2025$0.1715
May 30, 2025$0.1715
Mar 3, 2025$0.1715
Nov 29, 2024$0.1590
Aug 30, 2024$0.1590
May 31, 2024$0.1590
Feb 28, 2024$0.1590
Nov 29, 2023$0.1506
Jul 28, 2023$0.1506
May 30, 2023$0.1506
Feb 27, 2023$0.1506
Nov 29, 2022$0.1381
Jul 28, 2022$0.1381
May 27, 2022$0.1381
Feb 25, 2022$0.1381
Nov 29, 2021$0.1255
Jul 29, 2021$0.1255
May 27, 2021$0.1255
Feb 26, 2021$0.1255
Nov 27, 2020$0.1255
Jul 30, 2020$0.1255